HHS Awards $8.6M to UPenn for Lung-on-Chip Research on Chlorine Toxicity
Contract Overview
Contract Amount: $8,685,596 ($8.7M)
Contractor: Trustees of the University of Pennsylvania, the
Awarding Agency: Department of Health and Human Services
Start Date: 2020-09-21
End Date: 2028-02-29
Contract Duration: 2,717 days
Daily Burn Rate: $3.2K/day
Competition Type: FULL AND OPEN COMPETITION
Number of Offers Received: 1
Pricing Type: COST NO FEE
Sector: R&D
Official Description: TO SUPPORT THE DEVELOPMENT OF UPENN'S LUNG-ON-CHIP TECHNOLOGIES, TO EXAMINE CHLORINE-INDUCED RESPIRATORY COMPLICATIONS AND TO PREDICT THE TOXICITY OF INHALED CHLORINE GAS IN HUMAN LUNGS.
Place of Performance
Location: PHILADELPHIA, PHILADELPHIA County, PENNSYLVANIA, 19104
Plain-Language Summary
Department of Health and Human Services obligated $8.7 million to TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE for work described as: TO SUPPORT THE DEVELOPMENT OF UPENN'S LUNG-ON-CHIP TECHNOLOGIES, TO EXAMINE CHLORINE-INDUCED RESPIRATORY COMPLICATIONS AND TO PREDICT THE TOXICITY OF INHALED CHLORINE GAS IN HUMAN LUNGS. Key points: 1. Research focuses on critical health issues: lung damage from chlorine and predicting toxicity. 2. The contract supports advanced 'lung-on-chip' technology development at a leading university. 3. Long-term contract duration (2020-2028) suggests sustained research effort. 4. Funding is allocated to a specific research area within the Department of Health and Human Services.
Value Assessment
Rating: fair
The contract type is 'Cost No Fee', which is common for research and development where final costs are uncertain. The award amount of $8.6M over approximately 7.5 years averages to about $1.15M annually, which appears reasonable for specialized R&D.
Cost Per Unit: N/A
Competition Analysis
Competition Level: full-and-open
The contract was awarded under full and open competition, indicating multiple entities had the opportunity to bid. This method generally promotes competitive pricing and innovation.
Taxpayer Impact: Taxpayer funds are supporting critical public health research, aiming to improve understanding and mitigation of chemical inhalation risks.
Public Impact
Advances understanding of respiratory illnesses caused by chemical exposure. Develops novel technologies for medical research and testing. Enhances preparedness for public health emergencies involving toxic gases. Supports academic research and innovation in biotechnology. Potential for long-term public health benefits through improved medical insights.
Waste & Efficiency Indicators
Waste Risk Score: 50 / 10
Warning Flags
- Research outcomes are inherently uncertain and may not yield immediate practical applications.
- Long contract duration could be subject to scope creep or changing research priorities.
- Reliance on a single institution for this specific technology development.
Positive Signals
- Addresses a significant public health concern (chlorine toxicity).
- Utilizes advanced 'lung-on-chip' technology for more accurate modeling.
- Awarded through full and open competition, suggesting a robust selection process.
- Supports a reputable research institution (UPenn).
Sector Analysis
This contract falls within the scientific research and development sector, specifically focusing on biomedical engineering and toxicology. Spending benchmarks for similar R&D contracts can vary widely based on scope and duration, but this award appears aligned with significant, multi-year research initiatives.
Small Business Impact
The data indicates this contract was awarded to an educational institution (The Trustees of the University of Pennsylvania) and does not suggest any specific set-aside for small businesses. Therefore, the direct impact on small businesses is likely minimal unless they are subcontractors.
Oversight & Accountability
The contract is managed by the Department of Health and Human Services (HHS), specifically the Office of Assistant Secretary for Preparedness and Response (ASPR). ASPR is responsible for leading the nation's efforts to prevent, prepare for, and respond to public health emergencies, suggesting robust oversight for this type of research.
Related Government Programs
- Colleges, Universities, and Professional Schools
- Department of Health and Human Services Contracting
- Office of Assistant Secretary for Preparedness and Response Programs
Risk Flags
- Potential for research failure or inconclusive results.
- Long duration increases exposure to changing scientific landscapes.
- Cost-plus contract type can incentivize spending.
- Limited direct small business participation.
- Dependence on a single academic institution.
Tags
colleges-universities-and-professional-s, department-of-health-and-human-services, pa, definitive-contract, 1m-plus
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $8.7 million to TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE. TO SUPPORT THE DEVELOPMENT OF UPENN'S LUNG-ON-CHIP TECHNOLOGIES, TO EXAMINE CHLORINE-INDUCED RESPIRATORY COMPLICATIONS AND TO PREDICT THE TOXICITY OF INHALED CHLORINE GAS IN HUMAN LUNGS.
Who is the contractor on this award?
The obligated recipient is TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (Office of Assistant Secretary for Preparedness and Response).
What is the total obligated amount?
The obligated amount is $8.7 million.
What is the period of performance?
Start: 2020-09-21. End: 2028-02-29.
What are the key performance indicators (KPIs) for this research contract, and how will their achievement be measured to ensure value for money?
Key performance indicators would likely focus on milestones related to the development and validation of the lung-on-chip models, the accuracy of toxicity predictions, and the publication of research findings. Measurement would involve regular progress reports, peer review of data, and potentially independent validation of the technology. Ensuring value requires clear, measurable objectives tied to the contract's scientific goals and public health impact.
What are the primary risks associated with the long-term nature of this contract, and what mitigation strategies are in place?
Risks include potential shifts in research priorities, scientific challenges leading to delays or failure to achieve objectives, and budget overruns. Mitigation strategies may involve phased funding, regular reviews of research progress and relevance, flexibility to adjust research scope based on findings, and strong project management by ASPR to ensure accountability and adherence to goals.
How will the findings from this lung-on-chip research be translated into practical applications for public health preparedness and response?
Translation involves disseminating research findings through scientific publications, conferences, and direct engagement with public health agencies. The developed lung-on-chip models could be used by agencies like the CDC or EPA for more rapid and accurate assessment of chemical threats. ASPR's role in preparedness suggests a pathway for integrating these findings into emergency response protocols and risk assessment frameworks.
Industry Classification
NAICS: Educational Services › Colleges, Universities, and Professional Schools › Colleges, Universities, and Professional Schools
Product/Service Code: RESEARCH AND DEVELOPMENT › N – Health R&D Services
Competition & Pricing
Extent Competed: FULL AND OPEN COMPETITION
Solicitation Procedures: NEGOTIATED PROPOSAL/QUOTE
Solicitation ID: BAA-18-100-SOL-00003
Offers Received: 1
Pricing Type: COST NO FEE (S)
Evaluated Preference: NONE
Contractor Details
Address: 3451 WALNUT ST STE 440A, PHILADELPHIA, PA, 19104
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Educational Institution, Higher Education, Hospital, Nonprofit Organization, Not Designated a Small Business, Higher Education (Private), Special Designations
Financial Breakdown
Contract Ceiling: $8,685,596
Exercised Options: $8,685,596
Current Obligation: $8,685,596
Actual Outlays: $5,883,225
Subaward Activity
Number of Subawards: 3
Total Subaward Amount: $1,090,500
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES PROCEDURES NOT USED
Cost or Pricing Data: YES
Timeline
Start Date: 2020-09-21
Current End Date: 2028-02-29
Potential End Date: 2028-02-29 00:00:00
Last Modified: 2026-03-03
More Contracts from Trustees of the University of Pennsylvania, the
- Award of the Base to Upenn for Ceirr Contract 75N93021C00015. This Contract Will Support the Niaid Centers of Excellence for Influenza Research and Response (ceirr) — $59.3M (Department of Health and Human Services)
- Purpose: Award Base Contract in the Amount of $5,747,432 for the Service Entitle "bioinformatics Resource Centers for Infectious Diseases." — $29.6M (Department of Health and Human Services)
- Bioinformatics Resource Centers for Infectious Diseases - Base Period — $22.5M (Department of Health and Human Services)
- NEW Award From RFP Nih-Niaid-Dmid-Ai2008038 Bioinformatics Resource Center for Infectious Diseases. This IS ONE of Four Awards — $17.3M (Department of Health and Human Services)
- Randomized Clinical Trial of Genotype Guided Dosing of Warfarin Therapy — $12.4M (Department of Health and Human Services)
View all Trustees of the University of Pennsylvania, the federal contracts →
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →